Calcyte Therapeutics, Inc.

San Diego, CA 92130

SBIR Award Summary

Total Number of Awards 2
Total Value of Awards $453K
First Award Date 07/01/10
Most Recent Award Date 07/01/10

Key Personnel

Last Name Name Awards Contact
Zhang Bin Zhang 2

2 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-080
Budget: 07/01/10 - 12/31/11
PI: Bin Zhang

DESCRIPTION (provided by applicant): One specific focus and expertise of CalCyte Therapeutics Inc. is to develop and apply small molecule driven (i.e. chemically defined), stem cell based therapy to treat geographic atrophy (GA) from age-related macular degeneration (AMD). AMD affects 30-50 million people worldwide and 10 million people in the U...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-080
Budget: 07/01/10 - 12/31/11
PI: Bin Zhang

DESCRIPTION (provided by applicant): Age-related macular degeneration (AMD) is the most common cause of visual impairment of the elderly in developed countries. Despite its prevalence with the aging population, its etiology and pathogenesis are poorly understood and the treatment options are limited. CalCyte's scientific co-founder, Kang Zhang, ...